A detailed history of National Bank Of Canada transactions in Illumina, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 34,097 shares of ILMN stock, worth $4.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
34,097
Previous 34,097 -0.0%
Holding current value
$4.78 Million
Previous $4.45 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$105.28 - $135.9 $22.2 Million - $28.7 Million
-211,120 Reduced 86.1%
34,097 $4.45 Million
Q2 2024

Aug 02, 2024

SELL
$101.05 - $133.57 $13 Million - $17.2 Million
-129,090 Reduced 34.49%
245,217 $25.6 Million
Q1 2024

May 13, 2024

SELL
$127.73 - $147.2 $503,256 - $579,968
-3,940 Reduced 1.04%
374,307 $51.4 Million
Q4 2023

Feb 06, 2024

BUY
$92.79 - $142.53 $10.7 Million - $16.4 Million
114,834 Added 43.59%
378,247 $52.7 Million
Q3 2023

Oct 10, 2023

BUY
$128.91 - $192.44 $25.6 Million - $38.2 Million
198,667 Added 306.84%
263,413 $36.2 Million
Q2 2023

Jul 26, 2023

BUY
$183.43 - $232.67 $7.07 Million - $8.97 Million
38,536 Added 147.03%
64,746 $12.1 Million
Q1 2023

Apr 12, 2023

SELL
$193.75 - $232.55 $9.53 Million - $11.4 Million
-49,191 Reduced 65.24%
26,210 $6.1 Million
Q4 2022

Jan 24, 2023

BUY
$187.24 - $242.74 $7.42 Million - $9.62 Million
39,612 Added 110.68%
75,401 $0
Q3 2022

Oct 13, 2022

BUY
$177.23 - $227.44 $711,932 - $913,626
4,017 Added 12.64%
35,789 $6.78 Million
Q2 2022

Jul 28, 2022

BUY
$181.58 - $368.0 $644,972 - $1.31 Million
3,552 Added 12.59%
31,772 $5.9 Million
Q1 2022

May 05, 2022

SELL
$303.87 - $423.8 $7.39 Million - $10.3 Million
-24,305 Reduced 46.27%
28,220 $9.82 Million
Q4 2021

Jan 24, 2022

BUY
$347.28 - $421.83 $18.2 Million - $22.2 Million
52,525 New
52,525 $20 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.